Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002870195 | SCV003641900 | uncertain significance | Inborn genetic diseases | 2022-08-26 | criteria provided, single submitter | clinical testing | The c.6109A>G (p.S2037G) alteration is located in exon 38 (coding exon 38) of the DYNC2H1 gene. This alteration results from a A to G substitution at nucleotide position 6109, causing the serine (S) at amino acid position 2037 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |